Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Modestos Nakos Bimpos,
No information about this author
Katerina Karali,
No information about this author
Christine Antoniou
No information about this author
et al.
Acta Neuropathologica Communications,
Journal Year:
2024,
Volume and Issue:
12(1)
Published: June 17, 2024
Abstract
A
link
between
chronic
stress
and
Parkinson’s
disease
(PD)
pathogenesis
is
emerging.
Ample
evidence
demonstrates
that
the
presynaptic
neuronal
protein
alpha-synuclein
(asyn)
closely
tied
to
PD
pathogenesis.
However,
it
not
known
whether
system
dysfunction
present
in
PD,
if
asyn
involved,
if,
together,
they
contribute
neurodegeneration.
To
address
these
questions,
we
assess
axis
function
transgenic
rats
overexpressing
full-length
wildtype
human
(asyn
BAC
rats)
perform
multi-level
phenotyping
following
corticosterone
administration.
Stress
signaling,
namely
corticotropin-releasing
factor,
glucocorticoid
mineralocorticoid
receptor
gene
expression,
also
examined
post-mortem
patient
brains.
Overexpression
of
leads
HPA
dysregulation
rats,
while
administration
significantly
aggravates
nigrostriatal
degeneration,
serine129
phosphorylated
(pS129)
expression
neuroinflammation,
leading
phenoconversion
from
a
prodromal
an
overt
motor
phenotype.
Interestingly,
induces
robust,
twofold
increase
pS129
hypothalamus,
master
regulator
response,
hippocampus,
both
target
elevated
levels
altered
markers
signalling.
Finally,
defective
hippocampal
signalling
mirrored
brains
correlates
with
levels.
Taken
our
results
brain
provide
circulating
glucocorticoids
can
asyn-induced
neurodegeneration,
ultimately
triggering
PD.
Language: Английский
Psychological stress associated with prognostic uncertainties in recently diagnosed Parkinson’s disease patients: A qualitative study
Yasmin H. Aboelzahab,
No information about this author
Azadeh Bojmehrani,
No information about this author
Y Ahmed
No information about this author
et al.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(3), P. e0319576 - e0319576
Published: March 11, 2025
Background
Parkinson’s
disease
(PD)
is
a
common
neurodegenerative
disorder
that
negatively
impacts
thousands
of
patients
in
Canada.
The
unexpected
nature
PD
associated
with
decline
mental
health.
highest
level
psychological
stress
occurs
during
the
early
years
following
diagnosis.
Objectives
To
understand
prognostic
uncertainties
recently
diagnosed
patients,
uncover
gaps
current
support
systems,
and
recommend
areas
for
improvement
services
aim
to
decrease
receiving
Methods
An
exploratory
qualitative
study
was
conducted
using
semi-structured
interviews
13
more
than
6
months
less
5
years.
Participants
were
recruited
from
Toronto
Western
Hospital
Movement
Disorders
Clinic,
Toronto,
Ontario,
Canada
until
saturation
key
themes
reached.
Results
Five
major
identified
capturing
lived
experiences
diagnosis:
1)
circumstances
diagnosis
its
impact
on
2)
intrapersonal
factors
journey,
3)
role
social
relationships
patient’s
life,
4)
interaction
different
elements
healthcare
system,
5)
available
patients.
Conclusions
This
uncovers
burden
faced
by
due
insufficient
systems.
It
emphasizes
importance
patient-centered
approach
improving
their
quality
life
through
personalized
services.
Language: Английский
DRN-SNc serotonergic circuit drives stress-induced motor deficits and Parkinson’s disease vulnerability
Yibo Yao,
No information about this author
Chi Cui,
No information about this author
Yulong Shi
No information about this author
et al.
Neuropsychopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 17, 2025
Language: Английский
Study protocol for the MIND-PD study: a randomized controlled trial to investigate clinical and biological effects of mindfulness-based cognitive therapy in people with Parkinson’s disease
BMC Neurology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: June 25, 2024
Abstract
Background
People
with
Parkinson’s
disease
(PD)
are
very
sensitive
to
the
effects
of
stress.
The
prevalence
stress-related
neuropsychiatric
symptoms
is
high,
and
acute
stress
worsens
motor
symptoms.
Animal
studies
suggest
that
chronic
may
accelerate
progression,
but
evidence
for
this
in
humans
lacking.
Mindfulness-based
interventions
(MBIs)
train
participants
focus
on
present
moment,
purpose
without
judgement.
Previous
MBIs
alleviate
reduce
depression
anxiety
PD.
We
aim
demonstrate
efficacy
Mindfulness-Based
Cognitive
Therapy
(MBCT)
as
a
non-pharmacologic
treatment
strategy
(and
motor)
PD,
identify
mechanisms
underlying
reduction
Methods
In
prospective
randomized
controlled
trial
(RCT),
we
investigate
whether
8
weeks
MBCT,
compared
care
usual,
can
people
include
124
PD
patients,
who
experience
mild-moderate
depression,
eligible
magnetic
resonance
imaging
(MRI)
naïve
mindfulness,
have
duration
≤
10
years.
Every
participant
followed
12
months.
Clinical
biochemical
assessments
take
place
at
baseline
(T0),
after
2
months
(T1),
(T2);
MRI
T0
T2.
Our
primary
outcome
total
score
Hospital
Anxiety
Depression
Scale
(HADS)
T1,
while
correcting
HADS
T0,
age,
gender.
Beyond
testing
MBCT
explore
MBCT:
(1)
has
an
effect
symptom
severity,
(2)
influences
cerebral
markers
stress,
(3)
leads
change
biomarkers
progression.
Discussion
MIND-PD
one
first
RCTs
1-year
follow-up
possible
Insight
into
these
pave
way
new
methods
future.
Trial
registration
ClinicalTrials.gov,
NCT05779137.
Registered
January
2023.
Language: Английский
Evidence for a causal-mechanistic role for positive appraisal style in stress resilience
Published: May 20, 2024
Stress
resilience
is
the
maintenance
of
mental
health
despite
adversity.
We
have
predicted
that
a
tendency
to
appraise
stressors
in
realistic
slightly
unrealistically
positive
fashion
(positive
appraisal
style,
PAS)
prospectively
associated
with
more
resilient
outcomes;
PAS
proximal
and
integrative
factor,
mediating
pro-resilience
effects
other
protective
factors
(e.g.,
social
support);
modifiable,
changes
leading
corresponding
resilience.
In
two
independent
observational
samples
(N=132
N=1034),
we
find
predict
over
three
years
mediate
support.
Analyzing
multi-component
intervention
(N=232)
targets
broad
set
factors,
increases
this
mediates
intervention-induced
This
establishes
as
plastic
factor
likely
causal
on
Language: Английский
The MIND-PD study: a randomized controlled trial to investigate clinical and biological effects of Mindfulness-Based Cognitive Therapy in people with Parkinson’s disease
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 26, 2024
Abstract
Background
People
with
Parkinson’s
disease
(PD)
are
very
sensitive
to
the
effects
of
stress.
The
prevalence
stress-related
neuropsychiatric
symptoms
is
high,
and
acute
stress
worsens
motor
symptoms.
Animal
studies
suggest
that
chronic
may
accelerate
progression,
but
evidence
for
this
in
humans
lacking.
Mindfulness-based
interventions
(MBIs)
train
participants
focus
on
present
moment,
purpose
without
judgement.
Previous
MBIs
alleviate
reduce
depression
anxiety
PD.
We
aim
demonstrate
efficacy
Mindfulness-Based
Cognitive
Therapy
(MBCT)
as
a
non-pharmacologic
treatment
strategy
(and
motor)
PD,
identify
mechanisms
underlying
reduction
Methods
In
prospective
randomized
controlled
trial
(RCT),
we
investigate
whether
8
weeks
MBCT,
compared
care
usual,
can
people
include
124
PD
patients,
who
experience
mild-moderate
depression,
eligible
magnetic
resonance
imaging
(MRI)
naïve
mindfulness,
have
duration
≤
10
years.
Every
participant
followed
12
months.
Clinical
biochemical
assessments
take
place
at
baseline
(T0),
after
2
months
(T1),
(T2);
MRI
T0
T2.
Our
primary
outcome
total
score
Hospital
Anxiety
Depression
Scale
(HADS)
T1,
while
correcting
HADS
T0,
age,
gender.
Beyond
testing
MBCT
explore
MBCT:
(1)
has
an
effect
symptom
severity,
(2)
influences
cerebral
markers
stress,
(3)
leads
change
biomarkers
progression.
Discussion
MIND-PD
one
first
RCTs
1-year
follow-up
possible
Insight
into
these
pave
way
new
methods
future.
Trial
registration:
ClinicalTrials.gov,
NCT05779137.
Registered
January
2023.
Language: Английский
Experiences of Living With the Nonmotor Symptoms of Parkinson's Disease: A Photovoice Study
Laura J. Smith,
No information about this author
J. J. Callis,
No information about this author
Shannon Bridger‐Smart
No information about this author
et al.
Health Expectations,
Journal Year:
2024,
Volume and Issue:
27(3)
Published: June 1, 2024
Nonmotor
symptoms
(NMSs)
are
frequently
experienced
by
people
with
Parkinson's
disease
(PD)
and
often
perceived
as
their
most
bothersome
symptoms.
However,
these
remain
poorly
understood
suboptimal
clinical
management.
These
unmet
needs
an
important
determinant
of
health-related
quality
life
(QoL)
in
PD.
Language: Английский
Survey on Parkinson’s Disease Diagnosis Impact: Patients, Caregivers and Health Care Professionals’ Perspectives
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(14), P. 4118 - 4118
Published: July 14, 2024
Background:
The
announcement
of
Parkinson’s
disease
(PD)
diagnosis
may
provoke
negative
feelings
that
impact
the
ability
to
cope
with
and
all
life
changes
related
this
new
condition.
There
are
scarce
data
on
how
improve
communication
about
PD
which
factors
influence
outcome.
Methods:
We
performed
a
national
French
survey,
investigating
large
population
people
living
(PwPD),
who
recently
received
(≤1
year
since
diagnosis),
caregivers
health
care
professionals
(HCPs),
from
tertiary
community-based
hospitals.
Results:
A
total
397
PwPD
(45%
female
82%
>
50
years
old),
192
120
HCPs
(69%
neurologists)
completed
questionnaire.
was
not
expected
by
60%
induced
in
majority
(82%)
them.
Negative
experience
moment
were
male
gender
[OR
=
2.034,
CI
95%
1.09–3.78;
p
0.025]
older
age
1.05,
1.01–1.08;
0.004],
while
tremor
as
first
symptom
had
threshold
significance
1.78,
0.994–3.187;
0.052].
Half
considered
they
did
receive
enough
information
one
third
short-term
appointment
rediscuss
diagnosis.
expressed
willingness
have
multidisciplinary
follow-up
(PD
nurse,
psychologists).
Only
24%
been
trained
for
announcement.
Conclusions:
way
is
delivered
represents
pivotal
journey
caregivers.
This
process
requires
improvement
addressing
gaps
PwPD,
caregivers,
through
participatory
approach.
Language: Английский
The PRIME-NL study: evaluating a complex healthcare intervention for people with Parkinson’s disease in a dynamic environment
BMC Neurology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Aug. 3, 2024
An
innovative,
integrative
care
model
for
people
with
Parkinson
(PRIME
Parkinson)
has
gradually
been
implemented
in
a
selected
region
of
the
Netherlands
since
2021.
A
prospective
evaluation
this
(PRIME-NL
study)
was
initiated
parallel,
spanning
year
prior
to
implementation
(baseline)
and
period.
Following
publication
original
study
protocol,
COVID-19
crisis
delayed
full
PRIME
by
two
years
hampered
recruitment
participants.
Language: Английский
A systematic review of the factors associated with the psychological wellbeing of people with Parkinson’s in the COVID-19 pandemic
H. Gotheridge,
No information about this author
Fiona Eccles,
No information about this author
Craig Murray
No information about this author
et al.
Disability and Rehabilitation,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 12
Published: Sept. 11, 2024
The
lockdown
and
social
distancing
measures
introduced
as
a
result
of
the
COVID-19
pandemic
impacted
ability
people
with
Parkinson's
to
engage
in
normal
health
management
practices.
This
led
documented
reductions
psychological
wellbeing.
aim
present
review
was
identify
factors
associated
wellbeing
during
acute
stage
pandemic.
Language: Английский